Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders GlobeNewswire June 11, 2025 Collaboration will leverage Key2Brain's technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disorders Agreement is built on a partnership initiated in 2022, supporting continued development led by positive in […]

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer GlobeNewswire June 11, 2025 ALAMEDA, Calif., June 11, 2025 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the appointment of Anthony Baldor as Chief Financial Officer. Baldor succeeds Brigid A.

Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis GlobeNewswire June 11, 2025 –Achieves FDA Alignment on CMC and Non-Clinical Toxicology Regulatory Path for Nebokitug in PSC– –Preparations for the Nebokitug PSC Phase 3 Clinical Trial Advance as Discussions with Potential Strategic Partners Continue– TEL

ABM Selected to Provide Parking and Shuttle Transportation at Orlando International Airport GlobeNewswire June 11, 2025 ORLANDO, Fla., June 11, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, has been awarded a new contract by the Greater Orlando Aviation Authority (GOAA) to provide parking and employee shuttle

Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04 Engages with Cytel's Machine Learning Technology on Data Analysis and Phase 3 Trial Design GlobeNewswire June 11, 2025 GLEN ALLEN, Va., June 11, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing precision treatments for

Texas Holds Three of the Top Five Destination Cities for Consumer Migration TransUnion analysis finds significant generational differences in migration trends, with implications for insurers GlobeNewswire June 11, 2025 CHICAGO, June 11, 2025 (GLOBE NEWSWIRE) — Americans who relocated in 2024 sought out new locales, with the three most popular locations in the state of

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series GlobeNewswire June 11, 2025 HIGH POINT, N.C., June 11, 2025 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1

Quantic X-Microwave Enhances Modular RF Solutions with Altum RF Components New amplifier components from Altum RF now available as X-MWblocks(R) GlobeNewswire June 11, 2025 AUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) — Quantic X-Microwave(R), a business of Quantic Electronics(R) (“Quantic”) and leading provider of modular RF and microwave solutions, today announced the addition of Altum

RTI Connext Receives Industry Recognition as Leading Data Platform for Autonomous Systems Trusted by 45 of the top 50 defense companies, Connext delivers secure, scalable real-time data connectivity for the future of defense GlobeNewswire June 11, 2025 SUNNYVALE, Calif., June 11, 2025 (GLOBE NEWSWIRE) — Real-Time Innovations (RTI), the software framework company for physical AI

NANJING, China, June 11, 2025 (GLOBE NEWSWIRE) — From June 9 to 13, the China Grand Canal — listed as a UNESCO World Heritage Site — will symbolically “flow” into the heart of Brussels. This year's “Jiangsu Week,” themed around the Grand Canal Culture, offers an in-depth introduction to the canal's origins and its vital